Skip to main content
. 2015 Apr 28;11:1103–1109. doi: 10.2147/NDT.S68417

Figure 1.

Figure 1

Summary of lurasidone schizophrenia clinical trials.

Notes: Study 049 was the only study with negative results for currently used doses. *Study 229 and **Study 229E were conducted by Sunovion Pharmaceuticals Inc., Marlborough, MA, USA.

Abbreviations: OL, Open-label; DB, Double-blind.